Maternal Obesity and Obstetric Outcomes in a Socially Vulnerable Region Within Brazil's Unified Health System

Juliana A Dias1, Isabela C Guimarães2, Henrique César L Neves3

  • 1Faculdade de Medicina and Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, BRA.

Cureus
|January 16, 2026
PubMed

Introduction  Obesity is a major global public health challenge and a growing concern among women of reproductive age. In Brazil, more than half of these women are overweight, and obesity substantially increases the risk of gestational complications, particularly hypertension (HTN), diabetes, and cesarean delivery. High-risk prenatal care centers within the Brazilian Unified Health System (Sistema Único de Saúde, SUS) play a critical role in managing these conditions, especially in socioeconomically vulnerable regions. This study assessed the association between maternal obesity and childbirth outcomes in a high-risk prenatal care center serving the Jequitinhonha Valley, one of the country's most socially vulnerable areas. Methods  We conducted an institutional, cross-sectional study based on medical records from a State Specialized Care Center and its referral maternity hospital in Diamantina, Minas Gerais, Brazil. Pregnant women receiving high-risk prenatal care between 2021 and 2022 were included if they delivered at the referral hospital. Women with miscarriage, multiple gestation, or delivery elsewhere were excluded. Maternal, obstetric, and neonatal variables were analyzed across BMI categories according to WHO criteria. Statistical analyses included chi-square or Fisher's exact tests, Kruskal-Wallis tests, and multiple linear regression. A significance level of p < 0.05 was adopted. Results  Of 492 women assessed, 285 met the inclusion criteria. Obesity was prevalent in 56.5% of the sample. Obese women had significantly higher rates of cesarean delivery (64%) compared to overweight and eutrophic women (p = 0.046), with obese women being 1.6 times more likely to undergo a cesarean than overweight women and 2.6 times more likely than eutrophic women. Although the need for labor induction did not differ by BMI, indications for induction varied significantly, with hypertensive disorders occurring almost exclusively among overweight and obese women (p = 0.003). Neonatal outcomes, including Apgar scores and birth weight, did not differ significantly between BMI groups. Regression analysis showed gestational age (β = 0.427) and maternal BMI (β = 0.205) as independent predictors of birth weight. NICU admission was modest (1.75%), occurring mainly among premature infants of obese mothers. Conclusion  Maternal obesity was associated with increased obstetric intervention, particularly cesarean delivery and induction for hypertensive disorders. Despite this, neonatal outcomes were comparable across BMI categories, suggesting a potential protective effect of specialized high-risk prenatal care. These findings highlight the importance of strengthening structured, multidisciplinary obstetric services within the SUS, especially in vulnerable regions. Expanding access to reproductive planning and targeted prenatal care may help reduce adverse maternal outcomes. Future longitudinal studies are needed to identify which components of specialized care most effectively mitigate the risks associated with gestational obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169